Source link : https://www.newshealth.biz/health-news/fda-requests-more-info-on-pharmathers-ketamine-application/
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to PharmaTher citing deficiencies in the company’s abbreviated new drug application for racemic ketamine (Ketarx), the company said. “The deficiencies cited in the CRL are classified as minor,” the company said in a statement. “The FDA requested new and updated information […]
Author : News Health
Publish date : 2024-10-28 15:20:58
Copyright for syndicated content belongs to the linked Source.